Site Map
General Information
Center Directory
News and Events
Grants and Publications
Employment
E-mail access for CRCH
Staff only
Cancer Research Center of
Hawaii
Joe W. Ramos, Ph.D.
Assistant Professor (Researcher), Cancer Research Center of Hawaii;
Adjunct Associate Professor of Cell Biology, John A. Burns School of Medicine;
Graduate Faculty, Cell and Molecular Biology and Molecular Biosciences and Bioengineering
Ph.D. (Cell Biology),
University of Virginia
jramos@crch.hawaii.edu
Visit the Ramos
Lab website
Publication list via Pubmed
Cell-signaling, integrins, cell adhesion,
cancer
Our mission is to understand the regulation of the MAP kinase
pathway. In particular, we have focused on how activation of this ubiquitous
pathway can give rise to different outcomes in different cells. As a first step
in this work, we used expression cloning to isolate proteins that interfere with
ERK MAP kinase signaling to the cell adhesion proteins the integrins. One such
protein is PEA-15. PEA-15 can alter ERK signaling to other proteins as well,
including the transcription factor Elk1 and the kinase Rsk2.
PEA-15 is
widely expressed throughout the body, with particularly high levels expressed in
astrocytes and lymphocytes. The structure of PEA-15 is striking in that the
N-terminal half of the protein consists of a conserved death effector domain.
This domain is usually found in proteins involved in apoptosis. Indeed, PEA-15
prevents FADD-mediated apoptosis. The C-terminal half of the protein contains
two phosphorylated serines that appear to regulate PEA-15 function. Our work has
shown that PEA-15 binds directly to ERK and maintains it in the cytoplasm.
Similarly PEA-15 can also bind to Rsk2 and may therefore affect ERK activation
of Rsk2 in the cytoplasm. By determining the location in the cell of these
kinases PEA-15 can channel ERK signaling to cytoplasmic substrates to the
exclusion of nuclear targets like the transcription factor ELK1 and thus modify
the outcome of ERK activation.
We are using PEA-15 null mice and molecular
and cell biological approaches to better understand the function of PEA-15. We
have also begun to isolate and characterize related proteins. Because of the
fundamental nature of this work it has applications to a number of pathological
states including cancer and diabetes.
Active Grants
J.W. Ramos, Principal Investigator
R01-CA93849
“Regulation of Cell Signaling and Adhesion"
2002-2008
J.W. Ramos
Congressional Special Interest (CSI), Department of Defense (DOD), Medical Research Material Command (MRMC)
“Collaborative Cancer Research Program Between Tripler Army Medical Center and the Cancer Research Center of Hawai‘i(CRCH)"
2006-2009
Selected Publications
J.W. Ramos. (2008). The Regulation of Extracellular Signal-Regulated Kinase (ERK) in Mammalian Cells. IJBCB, 40(12):2707-2719.
H. Vaidyanathan, J. Opoku-Ansah, S. Pastorino, H. Renganathan, M.L. Matter and J.W. Ramos. (2007). ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15. PNAS, 105(50):19837-19842.
F. Renault-Mihara, F. Beuvon, X. Iturrioz, B. Canton, S. De Bouard, N. Léonard, S. Mouhamad, A. Sharif, J.W. Ramos, M-P. Junier, and H Chneiweiss. (2006). PEA-15 Expression Inhibits Astrocyte Migration by a PKC Delta-Dependent Mechanism. Mol. Biol. Cell, 17(12):5141-52.
H. Renganathan, H. Vaidyanathan, A. Knapinska and J.W. Ramos. (2005). Phosphorylation of PEA-15 Switches its Binding Specificity from ERK MAP kinase to FADD. Biochem J., 390(3):729-735.
H. Vaidyanathan and J.W. Ramos. (2003). Rsk2 activity is regulated by its association with PEA-15. J. Biol. Chem. 278(34):32367-32372.
J.W. Ramos*, E. Formstecher*, M. Fauquet, D.A. Calderwood, J-C. Hsieh, B. Canton, X-T. Nguyen, J-V. Barnier, J. Camonis, M.H. Ginsberg, and H. Chneiweiss. (2001). PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Developmental Cell 1:239-250. *Co-first authors.
©2005 Cancer Research Center of Hawaii. All rights reserved.
Email Comments and Questions: webmaster@crch.hawaii.edu